Asian Pacific Journal of Cancer Prevention

  • 제14권10호
  • /
  • Pages.6049-6053
  • /
  • 2013
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

High Incidence of Benign Brain Meningiomas among Iranian-born Jews in Israel may be Linked to both Hereditary and Environmental Factors

  • Barchana, Micha (School of Public Health, Faculty of Welfare and Health Sciences, University of Haifa) ;
  • Liphshitz, Irena (Israel National Cancer Registry, Ministry of Health)
  • 발행 : 2013.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Following research demonstrating an increased risk for meningiomas in the Jewish population of Shiraz (Iran) we conducted a cohort analysis of meningiomas among Jews originating in Iran and residing in Israel. Materials and Methods: We use the population-based registry data of the Israeli National Cancer Registry (INCR) for the main analysis. All benign meningioma cases diagnosed in Israel from January 2000 to the end of 2009 were included. Patients that were born in Iran, Iraq, Turkey, Bulgaria and Greece were used for the analysis, whereby we calculated adjusted incidence rates per 100,000 people and computed standardized incidence ratios (SIRs) comparing the Iranian-born to each of the three other groups. Results: Iranian-born Jews had statistically significant higher meningioma rates rates compared to other Jews originating in Balkan states: 1.46 fold compared to Turkish Jews and 1.86 fold compared to the Bulgaria-Greece group. There was a small increase in risk for the Iranian born group compared to those who were born in Iraq (1.06, not significant). Conclusions: Higher rates of meningiomas were seen in Jews originating in Iran that are living in Israel as compared to rates in neighboring countries of origin. These differences can be in part attributed to early life environmental exposures in Iran but probably in larger amount are due to genetic and hereditary factors in a closed community like the Iranian Jews. Some support for this conclusion was also found in other published research.

키워드

참고문헌

  1. Alimohamadi SM, Ghodsi SM, Ketabchi SE (2008). Epidemiologic patterns of primary brain tumors in Iran. Asian Pac J Cancer Prev, 9, 361-2.
  2. Bell DW, Varley JM, Szydlo TE, et al (1999). Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science, 286, 2528-31. https://doi.org/10.1126/science.286.5449.2528
  3. Blumenthal DT (2008). Familiality in brain tumors. Neurology, 71, 1015-20. https://doi.org/10.1212/01.wnl.0000326597.60605.27
  4. Claus EB, Bondy ML, Schildkraut JM, et al (2005). Epidemiology of intracranial meningioma. Neurosurgery, 57, 1088-95. https://doi.org/10.1227/01.NEU.0000188281.91351.B9
  5. Dinour D, Bahn A, Ganon L, et al (2011). URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews. Nephrol Dial Transplant, 26, 2175-81. https://doi.org/10.1093/ndt/gfq722
  6. Eskandary H, Sabba M, Khajehpour F, et al (2005). Incidental findings in brain computed tomography scans of 3000 head trauma patients. Surg Neurol, 63, 550-3. https://doi.org/10.1016/j.surneu.2004.07.049
  7. Fishler Y, Chitrit A, Barchana M, et al (2003). Examination of Israel national cancer data accumulation completeness for 1991. The National Center for Disease Control. Publication No. 230, Tel Hashomer, Israel (in Hebrew).
  8. Hamilton SR, Liu B, Parsons RE, et al (1999). The molecular basis of Turcot's syndrome. N Engl J Med, 332, 839-47.
  9. Hammer MF, Redd AJ, Wood ET, et al (1997). Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes. Proceedings of the National Academy of Sciences, 97, 6769-74.
  10. Inskip PD, Mellemkjaer L, Gridley G, et al (1998). Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control, 9, 109-16. https://doi.org/10.1023/A:1008861722901
  11. Inskip PD, Tarone RE, Hatch EE, et al (2003). Sociodemographic indicators and risk of brain tumors. Int J Epidemiol, 32, 225-33. https://doi.org/10.1093/ije/dyg051
  12. Jhawar BS, Fuchs CS, Colditz GA, et al (2003). Sex steroid hormone exposures and risk for meningioma. J Neurosurg. 99, 848-53. https://doi.org/10.3171/jns.2003.99.5.0848
  13. Kaback M, Lopatequi J, Portuges AR, et al (2010). Genetic screening in the Persian Jewish community: a pilot study. Genet Med, 10, 628-33.
  14. Kolles H, Niedermayer I, Schmitt C, et al (1995). Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien), 137, 174-81. https://doi.org/10.1007/BF02187190
  15. Levin A, Aizenberg A, Shvartzman P (1995). Benign meningioma following scalp irradiation in north African immigrants. Harefuah, 128, 676-7.
  16. Longstreth WT Jr, Phillips LE, Drangsholt M, et al (2004). Dental X-rays and the risk of intracranial meningioma: a population-based case-control study. Cancer, 100, 1026-34. https://doi.org/10.1002/cncr.20036
  17. Malmer B, Adatto P, Armstrong G, et al (2009). Gliogene an international consortium to understand familial Glioma. Cancer Epidemiol Biomarkers Prev, 16,1730-4.
  18. Mandel'shtam MI, Golubkov VI, Lamber EP, et al (2001). Search for frequently encountered mutations in genes predisposing to breast cancer. Genetika, 37, 1681-6.
  19. Mehrazin M, Rahmat H, Yavari P (2006). Epidemiology of primary intracranial tumors in Iran, 1978-2003. Asian Pac J Cancer Prev, 7, 283-8.
  20. Michaud DS, Gallo V, Schlehofer B, et al (2010). Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr, 92, 1145-50. https://doi.org/10.3945/ajcn.2010.29876
  21. Modan B (1997). Radiation policy: a decision-making model. Environ Health Perspect, 105, 1599-601.
  22. Modan B, Ron E, Werner A (1977). Thyroid cancer following scalp irradiation. Radiology, 123, 741-4. https://doi.org/10.1148/123.3.741
  23. Mukherjee B, Rennert G, Ahn J, et al (2011). High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterol, 140, 1919-26. https://doi.org/10.1053/j.gastro.2011.02.071
  24. Nasseri K, Mills JR (2009). Epidemiology of primary brain tumors in the middle eastern population in California, USA 2001-2005. Cancer Detect Prev, 32, 363-71. https://doi.org/10.1016/j.canep.2009.04.007
  25. Offit K, Levran O, Mullaney B, et al (2003). Shared genetic susceptibility to breast cancer, brain tumors, and fanconi anemia. J National Cancer Institute, 95, 20.
  26. Pecina-Slaus N, Nikuseva Martic T, Deak AJ, et al (2010). Genetic and protein changes of E-cadherin in meningiomas. J Cancer Res Clin Oncol, 136, 695-702. https://doi.org/10.1007/s00432-009-0708-z
  27. Poncz M, Ballantine M, Solowiejczyk D, et al (1982). Beta-thalassemia in a Kurdish Jew. Single base changes in the T-A-T-A box. J Biol Chem, 257, 5994-6.
  28. Preston-Martin S, Paganini-Hill A, Henderson BE, et al (1980). Case-control study of intracranial meningiomas in women in Los Angeles County, California, J Natl Cancer Inst, 65,67-73.
  29. Preston-Martin S (1989). Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiol, 8, 283-95. https://doi.org/10.1159/000110196
  30. Rajaraman P, Brenner AV, Neta G, et al (2010). Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol Biomarkers Prev, 19, 1356-61. https://doi.org/10.1158/1055-9965.EPI-09-1151
  31. Ron E, Modan B, Boice JD Jr (1988). Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol, 127, 713-25.
  32. Ron E, Modan B, Preston D, et al (1991). Radiation-induced skin carcinomas of the head and neck. Radiat Res, 125, 318-25. https://doi.org/10.2307/3578117
  33. Ruijs MW, Verhoef S, Rookus MA, et al (2010). TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet, 47, 421-8. https://doi.org/10.1136/jmg.2009.073429
  34. Sadetzki S, Modan B (1999). Epidemiology as a basis for legislation: how far should epidemiology go? Lancet, 353, 2238-9. https://doi.org/10.1016/S0140-6736(98)12327-9
  35. Sadetzki S, Chetrit A, Freedman L, et al (2005). Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Radiat Res, 164, 234. https://doi.org/10.1667/0033-7587(2005)164[0234:E]2.0.CO;2
  36. Seizinger BR, De la Monte S, Atkins L, et al (1987). Molecular genetic approach to human meningioma: Loss of genes on chromosome 22. Proc Natl Acad Sci USA, 84, 5419-23. https://doi.org/10.1073/pnas.84.15.5419
  37. Simon M, Bostrom JP, Hartmann C (2007). Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery, 60, 787-98.
  38. Surrey S, Delgrosso K, Malladi P, et al (1985). Analysis of a beta-globin gene containing a TATA box mutation from a Kurdish Jew with beta thalassemia. J Biol Chem, 260, 6507-10.
  39. Taghipour M, Razmkon A, Bakhtazad A (2010). High prevalence of intracranial meningioma in Jewish population in Shiraz, Southern Iran. Neurosurgery, 20, 68-70. https://doi.org/10.1097/WNQ.0b013e3181dcb220
  40. Terry MB, Howe G, Pogoda JM, et al (2009). An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol 19, 161-71.